+ Larger Font | - Smaller Font
Share


Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Consumer News New Drug Sponge Could Reduce Risk Of Side Effects From Cancer Treatment is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.
Search RobinsPost News & Noticias


Consumer News New Drug Sponge Could Reduce Risk Of Side Effects From Cancer Treatment | RobinsPost News & Noticias

Cancer drug trial provides lessons for future


A cancer drug was found to be ineffective in preventing recurrence of kidney cancer in patients who recently underwent tumor removal surgery, according to a clinical trial published in the Journal of ... Read More

Targeted Liver Cancer Treatment May Help Cut Side Effects


Drug-loaded 3D printed films could change cancer treatments forever as world-first research from the University of South Australia shows that new films ... side effects of traditional chemotherapy. Read More

Millions of Medicare Recipients Could Gain Access to Weight-Loss Drug


The FDA's approval of a new use for Wegovy potentially opens up access to the drug for more than 3 million people on Medicare, according to a new study. Read More

Opdivo side effects: What you should know


Opdivo (nivolumab) is a brand-name IV infusion that’s prescribed for some types of cancer ... risk of based on your Opdivo treatment plan. They can also advise you on when the side effects could ... Read More

Some breast cancer patients could be at risk of another type of cancer, study reveals


BREAST CANCER DRUG COULD HAVE POTENTIALLY SERIOUS SIDE EFFECT, NEW RESEARCH REVEALS In a statement sent to Fox News ... risk of developing second primary lung cancer, especially if their treatment ... Read More

Many Cancer Drugs Still Unproven 5 Years After Accelerated Approval


Many Cancer Drugs Still Unproven 5 Years After Accelerated Approval By Robin Foster HealthDay Reporter MONDAY, April 8, 2024 (HealthDay News) -- New research questions the effectiveness of the U.S ... Read More

How one state is trying to make weight loss drugs cheaper


The North Carolina state treasurer is taking on drugmakers Novo Nordisk and Eli Lilly in an attempt to lower drug costs for the state. So far, neither side is satisfied. Read More

A cheap drug may slow down aging. A study will determine if it works


Studies suggest people who take metformin for diabetes may be at lower risk for cancer, heart disease and dementia. Now researchers aim to test if it prevents age-related diseases in healthy people. Read More

Combining Drugs Into “Polypills” Could Reduce Cardiovascular Deaths


“And if polypills were widely accepted and used for prevention of cardiovascular disease, we would be in a much better position to equitably reduce the impact of cardiovascular disease globally. This ... Read More

Alzheimer's Risks and Treatment


A key component of Itzhaki’s theory was testing an antiviral drug that could alleviate the risk of senile ... through 18 months of treatment. There were some side effects, but they were ... Read More

Antidepressants and Depression


THE LENDER MAY BE SUBJECT TO FEDERAL LENDING LAWS. Home Warranty disclosure for New Jersey Residents: The product being offered is a service contract and is separate and distinct from any product ... Read More

Some breast cancer patients could be at risk of another type of cancer, study reveals


A new study found that women with breast cancer who have received chemotherapy are at an increased risk of developing lung cancer. Epic Research experts and other physicians commented. Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus